Statera BioPharma (FRA:7CB) Common Stock: €0.26 Mil (As of Sep. 2022)


FRA:7CB Statera BioPharma Inc FRA:7CB
20 GF Score
Price €2.61
View Full Analysis

What is Statera BioPharma Common Stock?

Statera BioPharma FRA:7CB 20 Common Stock is €0.26 Mil as of Sep. 2022. GuruFocus rates FRA:7CB with a GF Score™ of 20/100.

Statera BioPharma's quarterly common stock increased from Mar. 2022 (€0.23 Mil) to Jun. 2022 (€0.24 Mil) and increased from Jun. 2022 (€0.24 Mil) to Sep. 2022 (€0.26 Mil).

Statera BioPharma's annual common stock increased from Dec. 2019 (€0.02 Mil) to Dec. 2020 (€0.13 Mil) and increased from Dec. 2020 (€0.13 Mil) to Dec. 2021 (€0.16 Mil).

Statera BioPharma Common Stock Historical Data

* Premium members only.

The historical data trend for Statera BioPharma's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Statera BioPharma Common Stock Chart

Statera BioPharma Annual Data
Trend Dec19 Dec20 Dec21
Common Stock
0.02 0.13 0.16

Statera BioPharma Quarterly Data
Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.14 0.16 0.23 0.24 0.26
FRA:7CB
20GF Score
Statera BioPharma Inc FRA:7CB
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Statera BioPharma Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of €0.26 Mil mean?
Statera BioPharma (FRA:7CB) has a Common Stock of €0.26 Mil as of Sep. 2022. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Statera BioPharma and its competitors.
Is Statera BioPharma's Common Stock too high?
Statera BioPharma's current Common Stock is €0.26 Mil. Overall, Statera BioPharma has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Statera BioPharma's Common Stock compare to NRBO and PALI?
Statera BioPharma's Common Stock of €0.26 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Statera BioPharma and its competitors. Statera BioPharma's current Common Stock is €0.26 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Statera BioPharma stock overvalued right now?
Statera BioPharma (FRA:7CB) has a current Common Stock of €0.26 Mil. The current Common Stock is €0.26 Mil. Statera BioPharma's overall GF Score™ is 20/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Statera BioPharma (FRA:7CB), the current Common Stock is €0.26 Mil as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Statera BioPharma Business Description

Address 2580 East Harmony Road, Suite 316, Fort Collins, CO, USA, 80528
Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction. Its proprietary platform of Toll-like receptor drug candidates has applications in mitigation of radiation injury, mitigation of T-cell exhaustion, inflammation, T-cell exhaustion, immune system dysfunction, oncology, infection and neutropenia.
20GF Score

Get the complete analysis for FRA:7CB

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.61
Price